FDA Approves Triferic for Iron Replacement and Maintenance of Hemoglobin in Hemodialysis Patients

WIXOM, Mich., January 26, 2015 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for…
Drugs.com – New Drug Approvals

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us